Javed Khan

487 total citations
38 papers, 282 citations indexed

About

Javed Khan is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Javed Khan has authored 38 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in Javed Khan's work include CAR-T cell therapy research (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Computational Drug Discovery Methods (3 papers). Javed Khan is often cited by papers focused on CAR-T cell therapy research (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Computational Drug Discovery Methods (3 papers). Javed Khan collaborates with scholars based in United States, India and United Kingdom. Javed Khan's co-authors include Bowman Miao, Hossain Monshizadegan, Doree Sitkoff, Ginger Chao, Simon Low, Mian Gao, Daniel S. Meyers, Fabienne Denhez, Siew Peng Ho and Mark R. Witmer and has published in prestigious journals such as Neuron, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Javed Khan

34 papers receiving 275 citations

Peers

Javed Khan
Aimin Lin China
Barbara Perić Slovenia
Meilin Xu China
Pradhyumna Muralidharan India
Salim Shah United States
Min‐Soo Kim South Korea
Salaheldin S. Hamed United States
Veronica Balduzzi Italy
Stephanie Carr United States
Aimin Lin China
Javed Khan
Citations per year, relative to Javed Khan Javed Khan (= 1×) peers Aimin Lin

Countries citing papers authored by Javed Khan

Since Specialization
Citations

This map shows the geographic impact of Javed Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javed Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javed Khan more than expected).

Fields of papers citing papers by Javed Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javed Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javed Khan. The network helps show where Javed Khan may publish in the future.

Co-authorship network of co-authors of Javed Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Javed Khan. A scholar is included among the top collaborators of Javed Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javed Khan. Javed Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oberoi, Sapna, Catherine E. Cottrell, Douglas S. Hawkins, et al.. (2025). Integrated molecular characterization of pediatric soft tissue sarcomas: A report from the COG and CCDI molecular characterization initiative.. Journal of Clinical Oncology. 43(16_suppl). 10025–10025.
2.
Jennings, Victoria A., Alison Taylor, Natasha J. Caplen, et al.. (2024). Abstract B049: Oncolytic HSV1716-GMCSF combination strategies to remodel the immunosuppressive osteosarcoma tumor-microenvironment and promote anti-tumor immunity. Cancer Research. 84(17_Supplement). B049–B049. 2 indexed citations
3.
Khan, Javed, et al.. (2024). A Current Perspective on the Effects of Flavonoids in the Treatment of Acne. Infectious Disorders - Drug Targets. 25(3). e18715265299763–e18715265299763.
4.
5.
Khan, Javed, et al.. (2024). Bionanofactories for the Environmental Friendly Fabrication of SilverNanoparticles: Application to the Analysis of Antimicrobial Agents. Current Pharmaceutical Analysis. 20(2). 98–114. 2 indexed citations
6.
Kim, Yong, Robert G. Hawley, Teresa S. Hawley, et al.. (2023). Abstract 3538: Endogenous HiBiT-tagging of PAX3-FOXO1 identifies potent suppressors of PAX3-FOXO1 protein levels by high-throughput screening. Cancer Research. 83(7_Supplement). 3538–3538. 1 indexed citations
7.
Tian, Meijie, Adam Cheuk, David Milewski, et al.. (2023). Abstract 1784: FGFR4 and CD276 dual targeting CAR T cells demonstrate synergistic antitumor activity in childhood rhabdomyosarcoma. Cancer Research. 83(7_Supplement). 1784–1784. 1 indexed citations
8.
Khan, Javed, et al.. (2023). Potential Neuroprotective Strategies using Smart Drug Delivery Systemsfor Alzheimer’s Disease. Infectious Disorders - Drug Targets. 24(3). e231023222565–e231023222565. 2 indexed citations
9.
Masih, Katherine E., John A. Ligon, Bonnie Yates, et al.. (2021). Consequences of hemophagocytic lymphohistiocytosis‐like cytokine release syndrome toxicities and concurrent bacteremia. Pediatric Blood & Cancer. 68(10). e29247–e29247. 10 indexed citations
10.
Rahman, Mati ur, et al.. (2019). Phthalocyanines Derivatives as Control Approach for Antimicrobial Photodynamic Therapy. 2(3). 3 indexed citations
11.
Khan, Javed, et al.. (2018). Causes of Delayed Presentation of Acute Appendicitis and How it Affects Morbidity and Mortality. 8(1). 2 indexed citations
12.
Kim, Chul, Nitin Roper, Chuong D. Hoang, et al.. (2018). Local ablative therapy (LAT) for oligoprogressive, EGFR-mutant, non-small cell lung cancer (NSCLC) after treatment with osimertinib.. Journal of Clinical Oncology. 36(15_suppl). e21080–e21080. 5 indexed citations
13.
Braunschweig, Till, Joon‐Yong Chung, Chel Hun Choi, et al.. (2015). Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array. Diagnostic Pathology. 10(1). 53–53. 7 indexed citations
14.
Mitchell, Tracy, Ginger Chao, Doree Sitkoff, et al.. (2014). Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering. Journal of Pharmacology and Experimental Therapeutics. 350(2). 412–424. 103 indexed citations
15.
16.
Metaferia, Belhu, Jun S. Wei, Young Song, et al.. (2013). Development of Peptide Nucleic Acid Probes for Detection of the HER2 Oncogene. PLoS ONE. 8(4). e58870–e58870. 18 indexed citations
17.
Patel, Paresma, Hongmao Sun, Samuel Q. Li, et al.. (2013). Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & Medicinal Chemistry Letters. 23(15). 4398–4403. 26 indexed citations
18.
Metaferia, Belhu, Albert Lee, Alberto Plaza, et al.. (2010). Synthesis of novel cyclic NGR/RGD peptide analogs via on resin click chemistry. Bioorganic & Medicinal Chemistry Letters. 20(24). 7337–7340. 25 indexed citations
19.
Khan, Javed, Elizabeth Brint, Luke O'neill, & Lili Tong. (2004). CRYSTAL STRUCTURE OF THE TOLL/INTERLEUKIN-1 RECEPTOR (TIR) DOMAIN OF IL-1RAPL. Neuron. 45(1). 12198–12198. 1 indexed citations
20.
Chakravarthy, Murali, et al.. (2003). High thoracic epidural anesthesia as the sole anesthetic for redo off-pump coronary artery bypass surgery. Journal of Cardiothoracic and Vascular Anesthesia. 17(1). 84–86. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aimin Lin Breakdown of academic impact, for papers by Barbara Perić Breakdown of academic impact, for papers by Meilin Xu Breakdown of academic impact, for papers by Pradhyumna Muralidharan Breakdown of academic impact, for papers by Salim Shah Breakdown of academic impact, for papers by Min‐Soo Kim Breakdown of academic impact, for papers by Salaheldin S. Hamed Breakdown of academic impact, for papers by Veronica Balduzzi Breakdown of academic impact, for papers by Stephanie Carr
Rankless by CCL
2026